Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by Gobi Partners GBA
Advancing DNA vaccines & Immunotherapies for HIV, Cancers & Infectious Diseases HONG KONG SAR - Media OutReach - 27 July 2023 - Immuno Cure BioTech ("Immuno Cure ") is pleased to announce today that it has closed the US$12 million tranche in the US$27 million Series A fundraising round. Led by the AEF Greater Bay Area Fund that Gobi Partners...
Source: asiaone.com
